2Sciarra J J. Sexually transmitted disease: global importance[J]. Int J Gynecol Obstet, 1997, 58 : 107 - 119.
3Piot P, Islam MQ. Sexually transmitted disease in the 1990s. Global epidemiology and challenges for control[J ]. Sex Transm Dis, 1994,21:7 - 13.
4Marra CA, Patrick DM, Reynolds R, et al. Chlamydia trachomatis in adolescents and adults[J]. Pharmacoeconomics, 1998, 13:191-222.
5Susan D Hills, Riduan Joesoef, Polly A, et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility[J]. Am J Obstet Gynecol, 1993, 168:1 503 - 1 509.
6Barlow Rachael, Cooke lan D, Odukoya olusegun, et al. The prevalence of Chlamydia trachomatis in fresh tissue specimens from patients with ectopic pregnancy or tubal factor infertility aa determined by PCR and in - situ hybridisation[J]. The Journal of Medical Microbiology, 2001, 50(10):902-908.
7Marguerite B Barbacci, Michael R Spence, Elizabeth W Kapppus , et al. Postabortal endometritis and isolation of Chlamydia trachomatis [J].Obstetrics and Gynecology,1986, 68(5) :686- 690.
8Tita Mangione-Smith,June O' Leary, Elizabeth A Mcglynn. Health and cost- benefits of Chlamydia screening in young women[J]. Sex Transm Dis, 1999, 26(6) : 309 - 316.
9Guaschino, De Seta. Update on Chlamydia trachaomatis[J]. Annals of the New York Academy of Sciences, 2000, 900:293 - 300.
10A Eugene Washington, Peter S Arno, Marie A Brooks. The economic cost of pelvic inflammatory disease[J]. JAMA, 1986,255(13) :1 735 - 1 738.
